National Institute on Aging logo
Funder · Federal agency

National Institute on Aging

Funds aging and dementia research through the National Institute on Aging, including investigator support, company routes, and aging-care programs.

United Stateswww.nia.nih.gov
Key stats
Annual funding$4.529B
Programs7
Active grants2
Total grants8
About

The National Institute on Aging (NIA) is the NIH component that leads federal aging research. It is the second-largest NIH institute by budget, with an FY2026 enacted budget of about $4.53 billion, and its Division of Neuroscience holds most of the Alzheimer's disease and related dementias funding.

NIA backs basic science, translational work, and clinical studies across aging biology, Alzheimer's…

Programs & grants under this funder
Research on Current Topics in AD/ADRD

Funds independent Alzheimer and dementia studies led by investigators across biological and clinical approaches.

1 grant
NIA AD/ADRD R01 Research Grant
Discontinued
— pool
Research on Current Topics in AD/ADRD

Supports high-impact exploratory Alzheimer and dementia research through fast-turnaround innovative grant projects.

1 grant
NIA AD/ADRD R21 Exploratory Research Grant
Discontinued
— pool
Alzheimer's Disease Research Centers (ADRCs)

Funds core centre grants for major United States institutions coordinating dementia and Alzheimer science.

Alzheimer's Drug-Development Program (ADDP)

Funds preclinical and clinical drug development for Alzheimer disease through cooperative pathways.

1 grant
NIA Alzheimer's Drug-Development Program
Open
— pool·440 days
NIA Small Business Programs (SBIR & STTR)

Supports small United States businesses developing aging and dementia-related technologies through staged innovation funding.

3 grants
NIA SBIR Phase I
Between cycles
$146.0M pool
NIA SBIR Phase II
Between cycles
$146.0M pool
NIA STTR Phase I
Between cycles
$146.0M pool
NIA Start-Up Challenge and Accelerator

Funds US entrepreneurs and small businesses developing healthy-aging technologies through NIA's Start-Up Challenge cash prizes and accelerator.

1 grant
NIA Start-Up Challenge
Between cycles
— pool
NIA R01: Drug Repositioning and Combination Therapy for Alzheimer's Disease

Funds researchers combining computational and experimental approaches to test repositioned drugs for Alzheimer's disease treatment through NIH R01 grants.

1 grant
NIA R01: Drug Repositioning and Combination Therapy for Alzheimer's Disease
Open
— pool·44 days
Parent entityNational Institutes of Health
Last verified: 29 May 2026Source: www.nia.nih.gov